Le Lézard
Classified in: Health
Subjects: MAV, FVT, CPG, CFG

Media Advisory - Sanofi to announce significant investment in Canadian vaccine production facility


TORONTO, April 10, 2018 /CNW Telbec/ - Sanofi invites members of the media to the announcement of a landmark investment in lifesaving vaccine production in Canada. The investment will cement the company's Canadian operations as a key strategic asset for advancing public health both in this country and around the world, part of Sanofi's ongoing commitment to saving lives, preventing disease and delivering economic value.

Representatives from Sanofi, Sanofi Pasteur and Sanofi Canada, as well as officials from the Canadian and Ontario governments, will come together to mark this important announcement.

 

WHAT:

Announcement - Significant investment in vaccine production in Canada

WHO:
  • Hon. Navdeep Bains, Minister of Innovation, Science and Economic Development, Government of Canada
  • Hon. Steven Del Duca, Minister of Economic Development and Growth, Government of Ontario
  • Mr. David Loew, Executive Vice-President, Sanofi Pasteur
  • Mr. Philippe Luscan, Executive Vice-President, Head of Industrial Affairs, Sanofi
  • Mr. Vincent Hingot, Head of Industrial Affairs, Sanofi Pasteur
  • Ms. Niven Al-Khoury, President and CEO, Sanofi Canada

WHEN:

Thursday, April 12, 2018

11:30 am: News conference

12:15 pm: Media photo opportunity




NOTE: Please allow 30 minutes for security procedures upon arrival. Government-issued photo ID is required.

WHERE:

Sanofi Pasteur Canadian Headquarters

1755 Steeles Avenue West

Toronto (North York), Ontario

                           

SOURCE Sanofi Canada


These press releases may also interest you

at 23:00
GenScript Singapore's Open Day Reveals Pioneering AI Capabilities in Recombinant Protein Production and Drug Discovery
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

at 23:00
Tech Innovator Purba Majumder Recognized as One of North America's Top 100 Women Leaders in 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

at 22:33
Glycated Albumin Assay Market Projected to Reach $360.92 million by 2030 - Exclusive Report by 360iResearch
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

at 22:03
Health & Wellness Food Market Projected to Reach $859.43 billion by 2030 - Exclusive Report by 360iResearch
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

at 21:27
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas' XTANDItm (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Astellas Pharma Inc....

More news about Health...


News published on and distributed by: